[1] | Panagis G., Miliaressis E., Anagnostakis Y. and Spyraki C. (1995) Ventral Pallidum self-stimulation: A moveable electrode mapping study, Behavioural Brain Research, 168 (2), 165-172. |
[2] | Panagis G., Spyraki C. and Miliaressis E. (1995) Post-stimulation excitability of ventral pallidum self-stimulation neurons, Behavioral Neuroscience, 109 (4), 777-781. |
[3] | Panagis G. and Spyraki C. (1996) Neuropharmacological evidence for the role of dopamine in ventral pallidum self-stimulation, Psychopharmacology, 123 (3), 280-288. |
[4] | Nisell M., Nomikos G., Hertel P., Panagis G. and Svensson T.H. (1996) Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat, Synapse, 22, 369-381. |
[5] | Panagis G., Nisell M., Nomikos G.G., Chergui K. and Svensson T.H. (1996) Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat, Brain Research, 730, 133-142. |
[6] | Panagis G., Nomikos G.G., Miliaressis E., Chergui K., Kastellakis A., Svensson T.H. and Spyraki C. (1997) Ventral Pallidum self-stimulation induces stimulus dependent increase in c-fos expression in reward related brain regions, Neuroscience, 77, 175-186. |
[7] | Panagis G., Kastellakis A. and Spyraki C. (1998) Involvement of the ventral tegmental area opiate receptors in self-stimulation elicited from the ventral pallidum, Psychopharmacology, 139, 222-229. |
[8] | Nomikos G.G., Hildebrand B.E., Panagis G. and Svensson T.H. (1999) Nicotine withdrawal syndrome in the rat: role of α7 nicotinic receptors in the ventral tegmental area, Neuroreport, 10, 697-702. |
[9] | Hildebrand B.E., Panagis G., Svensson T.H. and Nomikos G.G. (1999) Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal: Role of nicotinic receptors in the ventral tegmental area, Neuropsychopharmacology, 21, 560-574. |
[10] | Panagis G., Hildebrand B.E., Svensson T.H. and Nomikos G.G. (2000) Selective c-fos induction and decreased dopamine release in the the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Synapse, 35, 15-25. |
[11] | Panagis G., Kastellakis A., Spyraki C. and Nomikos GG (2000) Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine-and cocaine-induced potentiation of brain stimulation reward, Psychopharmacology,149, 388-396. |
[12] | Schilström, B., Fagerquist, M.V., Zhang, X., Hertel, P., Panagis, G., Nomikos, G.G. and Svensson, T.H. (2000) Putative role of presynaptic a7 nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area, Synapse, 38, 375-383. |
[13] | Nomikos, G.G., Schilström, B., Hildebrand, B.E., Panagis, G., Grenhoff, J. and Svensson, T.H. (2000) Role of α7 nicotinic receptors in nicotine dependence and implications for psychiatric illness, Behavioural Brain Research, 113, 97-103. |
[14] | Panagis, G. and Kastellakis, A. (2002) The effects of ventral tegmental administration of GABAA, GABAB, NMDA and AMPA receptor agonists on ventral pallidum self-stimulation, Behavioural Brain Research, 131, 115-123. |
[15] | Vlachou, S., Nomikos, G.G. and Panagis, G. (2003) WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation, Behavioural Brain Research, 141, 215-222. |
[16] | Antoniou, K., Papathanasiou, G., Panagis, G., Nomikos, G.G., Hyphantis, T. and Papadopoulou-Daifoti, Z. (2004) Individual responses to novelty predict qualitative differences in d-amphetamine-induced open field but not reward-related behaviors in rats, Neuroscience, 123, 613-623. |
[17] | Vlachou, S., Nomikos, G.G. and Panagis G. (2005) CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat, Psychopharmacology, 179, 498-508. |
[18] | Antoniou, K., Galanopoulos, A., Vlachou, S., Kourouli, T., Nahmias, V., Thermos, K., Panagis, G., Daifoti, Z., Marselos, M., Papahatjis, D. and Spyraki, C. (2005) Behavioral pharmacological properties of a novel cannabinoid 1',1'-dithiolane Δ8-THC analog, AMG-3, Behavioural Pharmacology, 16, 499-510. |
[19] | Vlachou, S., Nomikos, G.G. and Panagis, G. (2006) Effects of endocannabinoid neurotransmission modulators on brain stimulation reward, Psychopharmacology, 188, 293-305. |
[20] | Vlachou, S., Nomikos, G.G., Stephens, D.N. and Panagis, G. (2007) Lack of appetitive effects of Δ9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents, Behavioural Pharmacology, 18, 311-319. |
[21] | Papathanasopoulos, P., Messinis, L., Lyros, E., Kastellakis, A. and Panagis, G. (2008) Multiple Sclerosis, Cannabinoids and Cognition, The Journal of Neuropsychiatry and Clinical Neurosciences, 20, 36-51. |
[22] | Vlachou, S., Stamatopoulou, F., Nomikos, G.G., & Panagis, G. (2008). Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine, International Journal of Neuropsychopharmacology, 11, 905-923. |
[23] | Panagis, G., Vlachou, S., & Nomikos, G.G. (2008). Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties, Current Drug Abuse Reviews, 1, 350-374. |
[24] | Mavrikaki, M., Nomikos, G.G., & Panagis, G. (2009). Effects of Mood Stabilizers on Brain Reward Processes in Rats: Studies Using the Intracranial Self-Stimulation Paradigm, European Neuropsychopharmacology, 19, 205-214. |
[25] | Messinis, L., Lyros, E., Andrian, V., Katsakiori, P., Panagis, G., Georgiou, V., & Papathanasopoulos, P. (2009). Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy, Human Psychopharmacology: Clinical and Experimental, 24, 524-531. |
[26] | Fokos, S., & Panagis, G. (2010). Effects of Δ9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress, Journal of Psychopharmacology, 24, 767-777. |
[27] | Mavrikaki, M., Nomikos, G.G., & Panagis, G. (2010). Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania, International Journal of Neuropsychopharmacology, 13, 541-548. |
[28] | Mavrikaki, M., Markaki, E., Nomikos, G.G., & Panagis, G. (2010). Chronic WIN55,212-2 elicits sustained and conditioned increases in intracranial self-stimulation thresholds in the rat, Behavioural Brain Research, 209, 114-118. |
[29] | Katsidoni, V., Apazoglou, K., & Panagis, G. (2011).Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine, Psychopharmacology, 213, 337-354. |